PLA2G7 - phospholipase A2 group VII Gene
Also Known as PAFAD; PAFAH; LP-PLA2; LDL-PLA2
Species: Homo sapiens
About PLA2G7
This gene has 2 transcripts (splice variants), 206 orthologues, 1 paralogue and is associated with 3 phenotypes. Broad expression in appendix (RPKM 6.4), lymph node (RPKM 5.5) and 18 other tissues.
Summary
The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2009]
PLA2G7 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001168357.2 | NP_001161829.1 | platelet-activating factor acetylhydrolase precursor |
| NM_005084.4 | NP_005075.3 | platelet-activating factor acetylhydrolase precursor |
| Molecular Function GO Annotation | Evidence | Références | Source |
|---|---|---|---|
| enables 1-alkyl-2-acetylglycerophosphocholine esterase activity |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| enables calcium-independent phospholipase A2 activity |
IDA
IDA: Inferred from direct assay
|
2040620 | GOA |
| enables phospholipid binding |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
28514442 | GOA |
| Biological Process GO Annotation | Evidence | Références | Source |
|---|---|---|---|
| involved in lipid oxidation |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| involved in low-density lipoprotein particle remodeling |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| involved in phosphatidylcholine catabolic process |
IDA
IDA: Inferred from direct assay
|
2040620 | GOA |
| involved in plasma lipoprotein particle oxidation |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| involved in platelet activating factor catabolic process |
IDA
IDA: Inferred from direct assay
|
16371369 | GOA |
| involved in platelet activating factor metabolic process |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| involved in positive regulation of monocyte chemotaxis |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
| Cellular Component GO Annotation | Evidence | Références | Source |
|---|---|---|---|
| part of high-density lipoprotein particle |
IDA
IDA: Inferred from direct assay
|
11590221 | GOA |
| part of low-density lipoprotein particle |
IDA
IDA: Inferred from direct assay
|
8624782 | GOA |
PLA2G7 Protein Structure
PAF-AH_p_II: Platelet-activating factor acetylhydrolase, isoform II (49 - 416)
- 0
- 100
- 200
- 300
- 400
- 441 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
platelet-activating factor acetylhydrolase |
|
PLA2G7 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | Références |
|---|---|---|---|---|---|---|---|
|
Intra
|
PLA2G7 | Q13093 | PTPRN | Homo sapiens | Q16849 | 28514442 | |
|
Intra
|
PLA2G7 | Q13093 | PTPRN | Homo sapiens | Q16849 | 33961781 |
Recombinant PLA2G7 Proteins
| Cat. No. | Nom du produit | Accession | Pureté |
|---|---|---|---|
| HY-P70993 | PLA2G7 Protein, Human (HEK293, His) | AAH38452.1 (F22-N441) | ≥ 90%, as determined by reducing SDS-PAGE. |
PLA2G7 Anticorps
| Cat. No. | Nom du produit | Application | Reactivity |
|---|---|---|---|
| HY-P84527 | PLA2G7 Antibody (YA4224) | IHC-P, ICC/IF, ELISA | Human |
| HY-P84527A | PLA2G7 Antibody (YA4224)(PBS only) | IHC-P, ICC/IF, ELISA | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Platelet-Activating Factor Acetylhydrolase Deficiency |
|
|
| Ige Responsiveness, Atopic |
|
|
| Asthma |
|
|
| Perinatal Necrotizing Enterocolitis |
|
|
| Lissencephaly 1 |
|
|
| Adult Respiratory Distress Syndrome |
|
|
| Intracranial Thrombosis |
|
|
| Atherosclerosis Susceptibility |
|
|
| Familial Hypercholesterolemia |
|
|
| Lissencephaly |
|
|
| Vascular Disease |
|
|
| Chronic Kidney Disease |
|
|
| Generalized Atherosclerosis |
|
|
| Lipid Metabolism Disorder |
|
|
| Juvenile Rheumatoid Arthritis |
|
|
| Myocardial Infarction |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Stroke, Ischemic |
|
|
| Cardiovascular System Disease |
|
|
| Type 2 Diabetes Mellitus |
|
|
| Type 1 Diabetes Mellitus |
|
|
| Carotid Artery Disease |
|
|
| Hypertension, Essential |
|
|
| Diabetes Mellitus |
|
|
| Dilated Cardiomyopathy |
|
|
| Heart Disease |
|
|
| Inflammatory Bowel Disease |
|
|
| Schizophrenia |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | PLA2G7 | MGD | MGI:1351327 |
| Felis catus | PLA2G7 | VGNC | VGNC:68885 |
| Rattus norvegicus | PLA2G7 | RGD | RGD:1310734 |
| Canis familiaris | PLA2G7 | VGNC | VGNC:44632 |
| Bos taurus | PLA2G7 | VGNC | VGNC:32965 |
| Macaca mulatta | PLA2G7 | VGNC | VGNC:76158 |
| Others | PLA2G7 | NCBI |